Token Test - Validation Study in Older Czech Adults and Patients with Neurodegenerative Diseases

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F17%3A00068402" target="_blank" >RIV/00159816:_____/17:00068402 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.14735/amcsnn2017300" target="_blank" >http://dx.doi.org/10.14735/amcsnn2017300</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.14735/amcsnn2017300" target="_blank" >10.14735/amcsnn2017300</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Token Test - Validation Study in Older Czech Adults and Patients with Neurodegenerative Diseases

Popis výsledku v původním jazyce

Aim: The study examines psychometric properties of the Czech version of the Token Test (TT) on a population of Czech seniors and individuals with neurodegenerative brain diseases. Participants and methods: The study included 96 individuals (mean age 67.7 years), of whom 43 were healthy controls (HC), 23 had incipient Alzheimer&apos;s disease or mild cognitive impairment due to Alzheimer&apos;s disease (AD + MCI), and 30 had Parkinson&apos;s disease (PD). Results: Significant differences in TT performance were found between the sample groups HC and AD + MCI (p &lt; 0.001) and between PD and AD + MCI (p &lt; 0.001). The highest convergent validity of TT was with the immediate reproduction of the Rey-Osterrieth complex figure (rho = 0.524; p &lt; 0.001), the Boston Naming Test (rho = 0.498; p &lt; 0.001) and the Mississippi Aphasia Screening Test (p = 0.486; p &lt;0.001). ROC analysis showed TT to discriminate with high precision for AD + MCI (AUC = 0.826), not for PN (AUC = 0.826). Conclusion: TT does not selectively evaluate the language function as such but it is selective for neurogenic communication disorders in patients with neurodegenerative brain disease.

Název v anglickém jazyce

Token Test - Validation Study in Older Czech Adults and Patients with Neurodegenerative Diseases

Popis výsledku anglicky

Aim: The study examines psychometric properties of the Czech version of the Token Test (TT) on a population of Czech seniors and individuals with neurodegenerative brain diseases. Participants and methods: The study included 96 individuals (mean age 67.7 years), of whom 43 were healthy controls (HC), 23 had incipient Alzheimer&apos;s disease or mild cognitive impairment due to Alzheimer&apos;s disease (AD + MCI), and 30 had Parkinson&apos;s disease (PD). Results: Significant differences in TT performance were found between the sample groups HC and AD + MCI (p &lt; 0.001) and between PD and AD + MCI (p &lt; 0.001). The highest convergent validity of TT was with the immediate reproduction of the Rey-Osterrieth complex figure (rho = 0.524; p &lt; 0.001), the Boston Naming Test (rho = 0.498; p &lt; 0.001) and the Mississippi Aphasia Screening Test (p = 0.486; p &lt;0.001). ROC analysis showed TT to discriminate with high precision for AD + MCI (AUC = 0.826), not for PN (AUC = 0.826). Conclusion: TT does not selectively evaluate the language function as such but it is selective for neurogenic communication disorders in patients with neurodegenerative brain disease.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30210 - Clinical neurology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Česká a slovenská neurologie a neurochirurgie

ISSN

1210-7859

e-ISSN

—

Svazek periodika

80

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

7

Strana od-do

300-306

Kód UT WoS článku

000402946400008

EID výsledku v databázi Scopus

—